Research ReportsBlue Jet Healthcare Q2 Results Review - New Projects To Start Contributing From H2: ICICI Securities
ADVERTISEMENT
Blue Jet Healthcare Q2 Results Review - New Projects To Start Contributing From H2: ICICI Securities
The company is building its new product pipeline of 12–15 molecules in the PI/API segment, which may help in sustaining growth momentum beyond FY26E, says the brokerage.
Close-up of a technician using pipette testing a chemical solution in a R&D laboratory. (Source: Freepik)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.